Skip to content

APOTHEEK VELGHE

Active
Public limited companyfounded 1991active for 34 yearsZottegemstraat 24, 9688 Maarkedal, BelgiumKBO/BCE: BE 0446.045.293
Summary

APOTHEEK VELGHE has been active since 1991 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €139,176 and a net result of -€33,317. Equity remains stable across the filed financial years (±0.5% per year). Its solvency ranks better than 23% of 5,004 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.8% (low).

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
8th oldest company in Maarkedal, Wholesale and retail trade sector1 site
Size
€1.1mtotal assets 2025
Staff
1.7 FTE
Equity
€139,176
Loss
-€33,317
Financial health
67 Healthy Checked score 2025
Bankruptcy probabilitywithin 12 months
0.8%
Structure
Parent
CAUTERMAN-VELGHE · 98.4%
  • Cauterman-Velghe BVManaging director · permanent representative Velghe Evelyn
  • Kristof CautermanDirector
Accounts filed 24 days late1 of 6 deeds read
Why 67raises riskEquity €139,176 (12.5% of total assets)Sector: Retail trade (NACE 47)lowers riskSize: 1.7 FTE, total assets €1.1mFounded in 1991Show the evidence

Checked score

Score 2025
67 / 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially better than 25% of its sector peers (NACE 47, micro)
Financial strength · tick = 2024
Weak
Solvency 37-2
equity 12.5% of total assets
Liquidity 32-8
short-term debt 40.8% · cash 1.1%
Profitability 27-13
return on assets -3.0%
Bankruptcy probability, 12 months
0.8% Low
0%0.5%1.5%4%10%≥ 25%

About 8 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,226 companies, NACE 47, micro)
Last 24 months 11-2024: 0.8% 12-2024: 0.8%● unchanged vs 11-2024 01-2025: 0.8%● unchanged vs 12-2024 02-2025: 0.8%● unchanged vs 01-2025 03-2025: 0.8%● unchanged vs 02-2025 04-2025: 0.8%● unchanged vs 03-2025 05-2025: 0.8%● unchanged vs 04-2025 06-2025: 0.8%● unchanged vs 05-2025 07-2025: 1.1%▲ +0.3 percentage points vs 06-2025highest value 08-2025: 0.4%▼ -0.7 percentage points vs 07-2025 09-2025: 0.4%● unchanged vs 08-2025 10-2025: 0.4%● unchanged vs 09-2025 11-2025: 0.4%● unchanged vs 10-2025 12-2025: 0.4%● unchanged vs 11-2025 01-2026: 0.4%● unchanged vs 12-2025 02-2026: 0.4%● unchanged vs 01-2026 03-2026: 0.4%● unchanged vs 02-2026 04-2026: 0.4%● unchanged vs 03-2026lowest value 05-2026: 0.4%● unchanged vs 04-2026 06-2026: 0.4%● unchanged vs 05-2026 07-2026: 0.5%▲ +0.1 percentage points vs 06-2026 08-2026: 0.9%▲ +0.4 percentage points vs 07-2026 09-2026: 0.8%▼ -0.1 percentage points vs 08-2026 10-2026: 0.8%● unchanged vs 09-2026
Credit of up to €9,000 on 30-day terms is acceptable
Liquidity tight (current ratio 1.27, compared with 1.06 in 2024, below the usual 1.5; short-term debt: 40.8% and cash: 1.1% of total assets), and 87.5% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 29% on solvency, 29% on liquidity, 24% on profitability and 20% on growth.

The bankruptcy probability was computed on 22-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
raises risk · Equity €139,176 (12.5% of total assets)
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
lowers risk · Size: 1.7 FTE, total assets €1.1m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Founded in 1991
Companies that have existed this long fail less often; how much that weighs depends on the rest of its profile.
KBO
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 23% of 5004 sector peers (2025).
NBB · sector comparison
Position among 5004 sector peers
Solvency
better than 23%
← weakest strongest →
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-08-2026, 24 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
24 days late
2024
13 days early
2023
29 days late
2022
70 days late
2021
80 days late
2020
31 days early
2019
35 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 28 days after the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 30 August (4 of the last 5 filed years within 43 days of that day).
Companies Code · seven months
Where today falls in the filing period
23-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · full…
  2. Weakest financial yearnet -€33,317
  3. Reappointments: Cauterman-Velghe BV (director) and Kristof…Permanent representative: Velghe Evelyn

Key points

  • Caution: Among the weakest 18% on net resultsector median €40,199 · 5,004 companies -€33,317 View
  • Controlled by CAUTERMAN-VELGHE 98.4% View
  • Active since 1991founded 11-12-1991 34 years View

By topic

Financials

Financial year
2025
Total assets
€1.1m
Loss
-€33,317
Solvency
12.5%
Total assets▼ 9.3%
Net result
20182025
Go to Financials

Board & ownership

Board
2 members
Parent
CAUTERMAN-VELGHE · 98.4%
  • Cauterman-Velghe BVManaging director
  • Kristof CautermanDirector
Go to Board & ownership

Timeline

Events
37
Since
1993
Next accounts
by 31-07-2027
  1. 18-07-2025Annual accounts filed
  2. 29-08-2024Annual accounts filed
  3. 09-10-2023Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Public limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
11-12-1991
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.